Burleson, TX, United States of America

W Dennis Dean

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: W Dennis Dean: Innovator in Ophthalmic Materials

Introduction

W Dennis Dean is a notable inventor based in Burleson, TX (US). He has made significant contributions to the field of ophthalmic materials, holding a total of 2 patents. His work focuses on developing innovative compounds that enhance the functionality of ophthalmic devices.

Latest Patents

Dean's latest patents include advancements in UV-absorbers for ophthalmic lens materials. These UV-absorbing compounds are particularly useful in ophthalmic devices, providing essential protection against harmful ultraviolet rays. Another significant patent involves 1-alkyl-3-aminoindazoles, where methods of making these compounds are described. The process includes reacting a 2-alkylaminobenzonitrile with a nitrosating agent, followed by reduction-cyclization of the resulting nitrosamine to form a 1-alkyl-3-aminoindazole. This compound can be further deaminated to produce a 1-alkylindazole, which can ultimately lead to the formation of desired indazoles that are preferably pharmaceutically active products.

Career Highlights

W Dennis Dean is associated with Alcon, Inc., a leading company in the field of eye care. His work at Alcon has allowed him to focus on developing innovative solutions that improve patient outcomes in ophthalmology.

Collaborations

Throughout his career, Dean has collaborated with notable colleagues, including David Jinkerson and Joseph I Weinschenk, III. These collaborations have contributed to the advancement of research and development in ophthalmic materials.

Conclusion

W Dennis Dean's contributions to the field of ophthalmic materials through his patents and collaborations highlight his role as an innovator. His work continues to impact the development of effective ophthalmic devices, ensuring better protection and treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…